Table 2 Metabolic activity of thoracic and extrathoracic adenopathies measured by the SUV max.

From: High metabolic activity in positron emission tomography and systemic inflammation occurring years after exposure cessation in engineered stone silicosis

Patient

Supraclavicular adenopathy

Right H-M adenophathy

Left H-M adenopathy

Subcarinal adenopathy

Lower thoracic adenopathy

Abdominal adenopathy

Average adenopathies

1

5.6

7.3

7.0

6.2

3.3

 

5.9

2

 

13.3

9.0

12.7

 

8.0

10.8

3

3.3

8.2

4.8

8.2

3.3

9.6

6.2

4

4.0

3.2

2.8

2.8

 

7.4

4.1

5

3.9

4.2

5.8

4.1

7.2

7.1

5.4

6

3.2

15.8

3.3

3.9

3.8

4.0

5.7

7

3.6

8.4

7.3

10.9

 

6.5

7.3

8

 

5.8

5.5

7.3

  

6.2

9

 

5.7

 

5.7

 

6.0

5.8

10

4.4

3.7

4.9

6.5

  

4.9

11

7.8

8.7

6.0

8.3

6.8

13.9

8.6

12

4.6

5.3

5.7

6.8

 

4.0

5.3

13

4.7

8.5

5.0

4.5

 

10.5

6.7

14

 

5.2

5.2

5.9

  

5.4

15

3.0

10.7

6.4

7.1

5.3

5.1

6.3

16

4.3

6.0

5.5

7.2

4.0

6.0

5.5

17

 

5.9

6.0

3.9

4.4

 

5.0

  1. H-M: hilar-mediastinal. Blank spaces: no significant adenopathies.